Blog

The relationship between human health and the microbes that live on and within us (our microbiome) is increasingly understood, particularly for the microbes living in our gut and the microbiome has, in recent years, become a target for specific therapeutics – including therapeutics based on the microbes themselves. Live biotherapeutics are microbes that deliver therapeutic […]

read more

Nuclear fusion has long held the promise of cheap, plentiful and, above all, clean energy with zero carbon emissions and minimal radiation issues that undermine public confidence in nuclear fission. The UK has been at the forefront of fusion research, hosting the Joint European Torus (JET) at the UK Atomic Energy Authority’s (UKAEA) site at […]

read more

UKI2S biotech company CellCentric, University of Cambridge spinout, has raised $26m to fund clinical testing of its first-in-class oncology drug candidate, CCS1477. CellCentric focuses on treating prostate cancer, as well as multiple other cancers. Their new drug candidate addresses the large and increasing population of patients – upwards of 80,000 people each year — who […]

read more

1 2 3 6